Greenbrook TMS Inc. (NASDAQ:GBNH) Receives $16.10 Consensus Price Target from Analysts

Shares of Greenbrook TMS Inc. (NASDAQ:GBNH – Get Rating) have been assigned a consensus recommendation of “Buy” from the eight research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation and six have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $16.10.

Several equities analysts have recently commented on the company. Zacks Investment Research cut Greenbrook TMS from a “hold” rating to a “sell” rating in a research note on Friday. Bloom Burton reissued a “buy” rating on shares of Greenbrook TMS in a research report on Monday, April 4th. Canaccord Genuity Group lowered Greenbrook TMS to a “buy” rating in a research report on Monday, February 7th. Finally, Clarus Securities dropped their price target on Greenbrook TMS from C$8.25 to C$7.50 in a research report on Monday, April 4th.

Hedge funds and other institutional investors have recently modified their holdings of the business. Rockefeller Capital Management L.P. acquired a new stake in Greenbrook TMS in the third quarter worth $109,000. AdvisorShares Investments LLC acquired a new stake in Greenbrook TMS in the third quarter worth $103,000. Virtu Financial LLC bought a new position in shares of Greenbrook TMS in the fourth quarter worth $288,000. Royal Bank of Canada grew its stake in shares of Greenbrook TMS by 243.1% in the third quarter. Royal Bank of Canada now owns 6,848 shares of the company’s stock worth $51,000 after purchasing an additional 4,852 shares in the last quarter. Finally, Masters Capital Management LLC grew its stake in shares of Greenbrook TMS by 55.6% in the fourth quarter. Masters Capital Management LLC now owns 700,000 shares of the company’s stock worth $2,954,000 after purchasing an additional 250,000 shares in the last quarter. 16.73% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Greenbrook TMS stock remained flat at $$2.87 on Friday. The stock had a trading volume of 3,445 shares, compared to its average volume of 16,927. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 2.26. The business’s 50-day simple moving average is $3.25 and its 200-day simple moving average is $4.79. Greenbrook TMS has a 12 month low of $2.73 and a 12 month high of $13.89.

Greenbrook TMS (NASDAQ:GBNH – Get Rating) last released its earnings results on Wednesday, March 30th. The company reported ($0.34) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.38) by $0.04. Greenbrook TMS had a negative return on equity of 189.28% and a negative net margin of 47.42%. During the same quarter in the previous year, the company posted ($0.60) earnings per share. As a group, equities analysts predict that Greenbrook TMS will post -1.21 earnings per share for the current fiscal year.

About Greenbrook TMS (Get Rating)

Greenbrook Tms, Inc engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Recommended Stories